Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients

Journal of Ovarian Research

Volumn 2, Issue 1, 2009, Pages

  Gallagher, Michael F ^a,b   Flavin, Richard J ^c   Elbaruni, Salah A ^a,b   McInerney, Jamie K ^a,b   Smyth, Paul C ^a   Salley, Yvonne M ^a,b   Vencken, Sebastian F ^a,b   O'Toole, Sharon A ^a   Laios, Alexandros ^a   Lee, Mathia Yc ^d   Denning, Karen ^a   Li, Jinghuan ^a   Aherne, Sinead T ^a   Lao, Kai Q ^e   Martin, Cara M ^a,b   Sheils, Orla M ^a   O'Leary, John J ^a,b  

^a ST JAMES S HOSPITAL   (Ireland)

^b Pathology Research Laboratory   (Ireland)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e APPLIED BIOSYSTEMS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; MICRORNA; RETINOIC ACID;

ARTICLE; BIOSYNTHESIS; CARCINOGENESIS; CELL DIFFERENTIATION; CHROMOSOME 14; CHROMOSOME 19; CLINICAL ASSESSMENT; CONTROLLED STUDY; EMBRYONAL CARCINOMA STEM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OVARY ADENOCARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 77953372578     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-2-19     Document Type: Article

References (100)

1. Identification of pancreatic cancer stem cells. C Li DG Heidt P Dalerba CF Burant L Zhang V Adsay M Wicha MF Clarke M Simeone, Cancer Res 2007 67 3 1030 1037 10.1158/0008-5472.CAN-06-2030 17283135
2. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. ME Prince R Sivanandan A Kaczorowski GT Wolf MJ Kaplan P Dalerba IL Weissman MF Clarke LE Allies, PNAS 2007 104 3 973 978 10.1073/pnas.0610117104 17210912
3. Ovarian cancer side population defines cells with stem-like characteristics and Mullerian Inhibiting Substance responsiveness. P Szotek R Pieretti-Vanmarke PT Masiakos DM Dinulescu D Connolly R Foster D Dombkowski F Preffer DT MacLaughlin PK Donahoe, PNAS 2006 103 30 11154 11159 10.1073/pnas.0603672103 16849428
4. Prospective identification of prostate cancer stem cells. AT Collins PA Berry C Hyde MJ Stower NJ Maitland, Cancer Res 2005 65 23 10946 51 10.1158/0008-5472.CAN-05-2018 16322242
5. Isolation and characterisation of tumourigenic, stem-like neural precursors from human glioblastoma. R Galli E Binda U Orfanelli E Cipelletti A Gritti S De Vitis R Fiocco C Foroin F Dimenoc A Vescovi, Cancer Res 2004 64 7011 7021 10.1158/0008-5472.CAN-04-1364 15466194
6. CD133, a novel marker for human prostatic epithelial stem cells. GD Richardson CN Robson SH Lang DE Neal NJ Maitland AT Collins, J Cell Sci 2004 117 16 3539 3545 10.1242/jcs.01222 15226377
7. Identification of human brain tumour initiating cells. SK Singh C Hawkins ID Clarke JA Squire J Bayani T Hide RM Henkelman MD Cusimano PB Dirks, Nature 2004 432 396 401 10.1038/nature03128 15549107
8. Prospective identification of tumourigenic breast cancer cells. M Al-Hajj MS Wicha A Benito-Hernandez SJ Morrison MF Clarke, PNAS 2003 100 3983 3988 10.1073/pnas.0530291100 12629218
9. Cancerous stem cells can arise from paediatric brain tumours. HD Hemmati I Nakano JA Lazareff M Masterman-Smith DH Geschwind M Bronner-Fraser HI Kornblum, PNAS 2003 100 15178 15183 10.1073/pnas.2036535100 14645703
10. Multipotentiality of single embryonal carcinoma cells. LJ Kleinsmith GB Pierce, Cancer Res 1964 24 1544 1552 14234000
11. Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. PW Andrews MM Martin AR Bahrami I Damjaov P Gokhale JS Draper, Biochem Soc Trans 2005 33 Pt 6 1526 30 16246161
12. From teratocarcinomas to embryonic stem cells. PW Andrews, Phil Trans R Soc Lond, B 2002 357 405 417 10.1098/rstb.2002.1058
13. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. PW Andrews I Damjanov D Simon GS Banting C Carlin NC Dracopoli J Fogh, Lab Invest 1984 50 2 147 162 6694356
14. Human embryonal carcinoma cells and their differentiation in culture. PW Andrews B Fenderson S Hakomori, Intl J Andrology 1987 10 1 95 104 10.1111/j.1365-2605.1987.tb00170.x
15. Cancer statistics. A Jemal R Siegel E Ward Y Hao J Xu T Murray MJ Thun, CA 2008 58 71 96 18287387
16. Cancer incidence, mortality and prevalence worldwide. JBF Ferlay P Pisani DM Parkin, IARC Press: Lyon, Globocon 2000 10828182
17. Classificaion of human ovarian tumours. RE Scully, Evviron Health Persp 1987 73 15 24 10.2307/3430594
18. Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype. NB Berry SA Bapat, J Ovarian Res 2008 1 8 10.1186/1757-2215-1-8 19025622
19. Molecular phenotyping of ovarian cancer stem cells unravel the mechanisms for repair and chemoresistance. AB Alvero R Chen H Fu M Montagna PE Schwarts T Rutherford D Silasi KD Steffenson M Waldstrom I Visintin G Mor, Cell Cycle 2009 8 1 158 166 19158483
20. Small miRNAs: keeping stem cells in line. BM Stadler H Ruohola-Baker, Cell 2008 132 563 566 10.1016/j.cell.2008.02.005 18295575
21. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Y Tay J Zhang AM Thompson B Lim I Rigoutsos, Nature 2008 455 2716 1124 8 10.1038/nature07299 18806776
22. MicroRNA-373 induces expression of genes with complementary promoter sequences. RF Place L Li D Pookot EJ Noonan R Dahija, PNAS 2008 105 5 1608 1613 10.1073/pnas.0707594105 18227514
23. OncomiRs: the discovery and progress of microRNAs in cancer. WC Cho, Mol Cancer 2007 6 60 10.1186/1476-4598-6-60 17894887
24. OncomiRs-microRNAs with a role in cancer. A Esquela-Kerscher FJ Slack, Nature Rev Cancer 2006 6 259 69 10.1038/nrc1840
25. Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement map. F Micci J Weimer L Haugom RI Skotheim R Grunewald VM Abeler I Silins RA Lothe CG Trope N Arnold S Heim, Genes, Chrom Cancer 2009 48 2 184 93 10.1002/gcc.20628
26. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. L Zhang S Volinia T Bonome GA Calin J Greshock N Yang CG Liu A Giannakakis P Alexiou K Hasegawa CN Johnstone MS Megraw S Adams H Lassus J Huang S Kaur S Liang P Sethupathy A Leminen VA Simossis R Sandaltzopoulos Y Naomoto D Katsaros PA Gimotty A DeMichele Q Huang R Bützow AK Rustgi BL Weber MJ Birrer AG Hatzigeorgiou CM Croce G Coukos, PNAS 2008 105 19 7004 9 10.1073/pnas.0801615105 18458333
27. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. A Ventura AG Young MM Winslow L Lintault A Meissner SJ Erkeland J Newman RT Bronson D Crowley JR Stone R Jaenisch PA Sharp T Jacks, Cell 2008 132 5 875 86 10.1016/j.cell.2008.02.019 18329372
28. Augmentation of tumour angiogenesis by a Myc-activated microRNA cluster. M Dews A Homayouni D Yu D Murphy C Sevignani E Wentzel EE Furth WM Lee GH Enders JT Mendell A Thomas-Tikhonenko, Nature Genet 2006 38 9 1060 5 10.1038/ng1855 16878133
29. A microRNA polycistron as a potential human oncogene. L He JM Thomson MT Hemann E Hernando-Monge D Mu S Goodson S Powers C Cordon-Cardo SW Lowe GJ Hannon SM Hammond, Nature 2005 9 828 833 10.1038/nature03552
30. MicroRNA signatures in cancer. GA Calin CM Croce, Nature Rev Cancer 2006 6 857 866 10.1038/nrc1997
31. Multi-plexing RT-PCR for the detection of multiple miRNA species in small samples. K Lao NL Xu V Yeung C Chen KJ Livak NA Straus, Biochem Biophys Res Comm 2006 343 85 9 10.1016/j.bbrc.2006.02.106 16529715
32. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ddCt method. KJ Livak TD Schmittgen, Methods 2001 25 402 8 10.1006/meth.2001.1262 11846609
33. miRBase: tools for microRNA genomics. S Griffiths-Jones HK Saini S van Dongen AJ Enright, Nucleic Acids Res 2008 36 154 D158 10.1093/nar/gkm952 17991681
34. miRGen: A database for the study of animal microRNA genomic organisation and function. M Megraw P Sethupathy B Corda AG Hatzigeorgiou, Nucleic Acids Res 2006 35 149 D155 10.1093/nar/gkl904 17108354
35. Altered eIF6 and dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients. RJ Flavin PC Smyth SP Finn A Laois SA O'Toole C Barrett M Ring KM Denning J Li AT Aherne NA Aziz A Alhadi BL Sheppard M Loda C Martin OM Sheils JJ O'Leary, Mod Path 2008 21 676 684 10.1038/modpathol.2008.33
36. MicroRNA expression and identification of putative miRNA targets in ovarian cancer. N Dahiya CA Sherman-Baust TL Wang B Davidson M Shih Ie Y Zhang W Wood KG Becker PJ Morin, PLoS ONE 2008 3 2436 10.1371/journal.pone.0002436 18560586
37. MicroRNA signatures in human ovarian cancer. MV Iorio R Visone G Di Leva V Donati F Petrocca P Casalini C Taccioli S Volinia GC Lui H Aider GA Calin S Menard CM Croce, Cancer Res 2007 67 8699 707 10.1158/0008-5472.CAN-07-1936 17875710
38. MicroRNA expression profiles in serous ovarian carcinoma. EJ Nam H Yoon SW Kim H Kim YT Kim JH Kim JW Kim S Kim, Clin Cancer Res 2008 14 9 2690 5 10.1158/1078-0432.CCR-07-1731 18451233
39. MicroRNA signatures of tumour-derived exosomes as diagnostic biomarkers of ovarian cancer. DD Taylor C Gercel-Taylor, Gynae Oncol 2008 110 1 13 21 10.1016/j.ygyno.2008.04.033
40. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. N Yang S Kaur S Volinia J Greshock H Lassus K Hasegawa S Liang A Leminen S Deng L Smith CN Johnstone XM Chen CG Liu Q Huang D Katsaros GA Calin BL Weber R Bützow CM Croce G Coukos L Zhang, Cancer Res 2008 68 24 10307 14 10.1158/0008-5472.CAN-08-1954 19074899
41. Dicer, Drosha and outcomes in patients with ovarian cancer. WM Merritt YG Lin LY Han AA Kamat WA Spannuth R Schmandt D Urbauer LA Pennacchio JF Cheng AM Nick MT Deavers A Mourad-Zeidan H Wang P Mueller ME Lenburg JW Gray S Mok MJ Birrer G Lopez-Berestein RL Coleman M Bar-Eli AK Sood, N Engl J Med 2008 359 25 2641 50 10.1056/NEJMoa0803785 19092150
42. Testicular germ cell tumour susceptibility genes from the consomic 129. MOLF-Chr19 mouse strain. R Zhu Y Ji L Xiao A Matin, Mamm Gene 2007 18 584 95 10.1007/s00335-007-9036-2
43. MicroRNA fingerprints during megakaryocytopoiesis. R Garzon F Pichiorri T Palumbo R Iuliano A Cimmino R Aqeilan S Volinia D Bhatt H Alder G Marcucci GA Calin CG Liu CD Bloomfield M Andreeff CM Croce, PNAS 2006 103 13 5078 83 10.1073/pnas.0600587103 16549775
44. Mir-199a, a bone morphogenic protein 2-response microRNAs, regulates chondrogenesis via direct targeting to Smad1. EA Lin L Kong XH Bai Y Luan CJ Liu, J Biol Chem 2009 284 17 11326 35 10.1074/jbc.M807709200 19251704
45. MyoD inhibits Fstl1 and Utrn expression by inducing expression of miR-206. MI Rosenberg SA Georges A Asawachaicharn E Analau SJ Tapscott, J Cell Biol 2009 175 1 77 85 10.1083/jcb.200603039
46. Efficient tumour formation by single human melanoma cells. E Quintana M Shackleton MS Sabel DR Fullen TM Johnston SJ Morrison, Nature 2008 456 7222 593 8 10.1038/nature07567 19052619
47. Profilin miRNA expression in hepatocellular carcinoma reveals microRNAs-244 up-regulation and apoptosis inhibitor-5 as a microRNAs-224- specific target. Y Wang AT Lee JZ Ma J Wang J Ren Y Yang E Tantoso KB Li LL Ooi P Tan CG Lee, J Biol Chem 2008 283 19 13205 15 10.1074/jbc.M707629200 18319255
48. Systematic validation of predicted targets for cyclinD1. Q Jiang MG Feng YY Mo, BMC cancer 2009 9 194 10.1186/1471-2407-9-194 19538740
49. MicroRNAs: regulators of oncogenesis and stemness. T Papagiannakopoulos KS Kosik, BMC Med 2008 6 15 10.1186/1741-7015-6-15 18577221
50. The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. T Sun Q Wang S Balk M Brown GS Lee P Kantoff, Cancer Res 2009 69 8 3356 63 10.1158/0008-5472.CAN-08-4112 19351832
51. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia. X Ju D Li Q Shi H Hou N Sun B Shen, J Pediatr Hematol Oncol 2009 26 1 1 10 10.1080/08880010802378338
52. Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma. JL Robertus G Harms T Blokzijl M Booman D de Jong G van Imhoff S Rosati E Schuuring P Kluin A van den Berg, Mod Path 2009 22 4 547 55 10.1038/modpathol.2009.10
53. MicroRNAs expressed during lung cancer development are expressed in human pseudoglandular lung embryogenesis. A Navarro RM Marrades N Vĩolas A Quera C Agustí A Huerta J Ramirez A Torres M Monzo, Oncology 2009 76 3 162 9 10.1159/000201569 19209007
54. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Y Guo Z Chen L Zhang F Zhou S Shi X Feng B Li X Meng X Ma M Luo K Shao N Li B Qiu K Mitchelson J Cheng J He, Cancer Res 2008 68 1 26 33 10.1158/0008-5472.CAN-06-4418 18172293
55. Epigenetic Silencing of MicroRNA miR-107 Regulates Cyclin-Dependent Kinase 6 Expression in Pancreatic Cancer. KH Lee C Lotterman C Karikari N Omura G Feldmann N Habbe MG Goggins JT Mendell A Maitra, Pancreatology 2009 9 3 293 301 10.1159/000186051 19407485
56. Over- and under-expressed microRNAs in human colorectal cancer. K Motoyama H Inoue Y Takatsuno F Tanaka K Mimori H Uetake K Sugihara M Mori, Intl J Oncol 2009 34 4 1069 75
57. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. M Mraz S Pospisilova K Malinova I Slapak J Mayer, Leuk Lymphoma 2009 50 3 506 9 10.1080/10428190902763517 19347736
58. MicroRNA profile analysis of human prostate cancers. AW Tong P Fulgham C Jay P Chen I Khalil S Liu N Senzer AC Eklund J Han J Nemunaitis, Cancer Gene Ther 2009 16 3 206 16 18949015
59. MicroRNA signatures predict estrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. AJ Lowery N Miller A Devaney RE McNeill PA Davoren C Lemetre V Benes S Schmidt J Blake G Ball MJ Kerin, Breast Cancer Res 2009 11 27 10.1186/bcr2257 19432961
60. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. YK Kim J Yu TS Han SY Park B Namkoong DH Kim K Hur MW Yoo HJ Lee HK Yang VN Kim, Nucleic Acids Res 2009 37 5 1672 81 10.1093/nar/gkp002 19153141
61. Role of microRNAs in drug-resistant ovarian cancer cells. A Sorrentino CG Liu A Addario C Peschle G Scambia C Ferlini, Gynecol Oncol 2008 111 3 478 86 10.1016/j.ygyno.2008.08.017 18823650
62. Prognostic Values of microRNAs in Colorectal Cancer. Y Xi A Formentini M Chien DB Weir JJ Russo J Ju M Kornmann J Ju, Biomark Insights 2006 2 113 121 18079988
63. MicroRNA expression alterations are linked to tumourigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. AE Szafranska TS Davison J John T Cannon B Sipos A Maghnouj E Labourier SA Hahn, Oncogene 2007 26 30 4442 52 10.1038/sj.onc.1210228 17237814
64. Uncovering growth-suppressive MicroRNAs in lung cancer. X Liu LF Sempere F Galimberti SJ Freemantle C Black KH Dragnev Y Ma S Fiering V Memoli H Li J DiRenzo M Korc CN Cole M Bak S Kauppinen E Dmitrovsky, Clin Cancer Res 2009 15 4 1177 83 10.1158/1078-0432.CCR-08-1355 19228723
65. Molecular assays for the detection of microRNAs in prostate cancer. AC Siva LJ Nelson CL Fleischer M Majlessi MM Becker RL Vessella MA Reynolds, Molec Cancer 2009 8 17 10.1186/1476-4598-8-17
66. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. TS Wong XB Liu BY Wong RW Ng AP Yuen WI Wei, Clin Cancer Res 2008 14 9 2588 92 10.1158/1078-0432.CCR-07-0666 18451220
67. Evolution of microRNA expression during human bronchial squamous carcinogenesis. C Mascaux JF Laes G Anthoine A Haller V Ninane A Burny JP Sculier, Eur Resp J 2009 33 2 352 9 10.1183/09031936.00084108
68. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma-A miRNA microarray analysis. M Guled L Lahti PM Lindholm K Salmenkivi I Bagwan AG Nicholson S Knuutila, Gene Chrom Cancer 2009 48 7 615 23 10.1002/gcc.20669
69. Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. RJ Webster KM Giles KJ Price PM Zhang JS Mattick PJ Leedman, J Biol Chem 2009 284 9 5731 41 10.1074/jbc.M804280200 19073608
70. The Role of miR-206 in The Epidermal Growth Factor (EGF) Induced Repression of Estrogen Receptor-alpha (ER{alpha}) Signaling and a Luminal Phenotype in MCF-7 Breast Cancer Cells. BD Adams DM Cowee BA White, Molec Endocrinol 2009 23 8 1215 30 10.1210/me.2009-0062
71. Pre-micro RNA signatures delineate stages of endothelial cell transformation in kaposi sarcoma. AJ O'Hara P Chugh L Wang EM Netto E Luz WJ Harrington BJ Dezube B Damania DP Dittmer, PLoS Pathogens 2009 5 4 1000389 10.1371/journal.ppat.1000389 19381257
72. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma. W Wu Z Lin Z Zhuang X Liang, Eur J Cancer Prev 2009 18 1 50 55 10.1097/CEJ.0b013e328305a07a 19077565
73. Detailed characterization of a homozygously deleted region corresponding to a candidate tumour suppressor locus at 21q11-21 in human lung cancer. H Yamada K Yanagisawa S Tokumaru A Taguchi Y Nimura H Osada M Nagino T Takahashi, Gene Chrom Cancer 2008 47 9 810 8 10.1002/gcc.20582
74. An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma. D Ronchetti M Lionetti L Mosca L Agnelli A Andronache S Fabris GL Deliliers A Neri, BMC Med Genom 2008 1 37 10.1186/1755-8794-1-37
75. Transcriptional inhibition of Hoxd4 expression by miRNA-10a in human breast cancer cells. Y Tan B Zhang T Wu G Skogerbø X Zhu X Guo S He R Chen, BMC Molec Biol 2009 10 12 10.1186/1471-2199-10-12
76. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. X Agirre A Jiménez-Velasco E San José-Enériz L Garate E Bandrés L Cordeu O Aparicio B Saez G Navarro A Vilas-Zornoza I Pérez-Roger J García-Foncillas A Torres A Heiniger MJ Calasanz P Fortes J Romn-Gámez F Prásper, Molec Cancer Res 2008 6 12 1830 40 10.1158/1541-7786.MCR-08-0167
77. Widespread deregulation of microRNA expression in human prostate cancer. M Ozen CJ Creighton M Ozdemir M Ittmann, Oncogene 2008 27 12 1788 93 10.1038/sj.onc.1210809 17891175
78. Suppression of non-small cell lung tumour development by the let-7 microRNA family. MS Kumar SJ Erkeland RE Pester CY Chen MS Ebert PA Sharp T Jacks, PNAS 2008 105 10 3903 8 10.1073/pnas.0712321105 18308936
79. Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer. G Nakajima K Hayashi Y Xi K Kudo K Uchida K Takasaki M Yamamoto J Ju, Cancer Genom Proteom 2006 3 5 317 324
80. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. L Garzia I Andolfo E Cusanelli N Marino G Petrosino D De Martino V Esposito A Galeone L Navas S Esposito S Gargiulo S Fattet V Donofrio G Cinalli A Brunetti LD Vecchio PA Northcott O Delattre MD Taylor A Iolascon M Zollo, PLoS ONE 2009 4 3 4998 10.1371/journal.pone.0004998 19308264
81. Retroviral activation of the mir-106a microRNA cistron in T lymphoma. AM Lum BB Wang L Li N Channa G Bartha M Wabl, Retrovirol 2007 4 5 10.1186/1742-4690-4-5
82. microRNA expression profile in undifferentiated gastric cancer. T Katada H Ishiguro Y Kuwabara M Kimura A Mitui Y Mori R Ogawa K Harata Y Fujii, Intl J Oncol 2009 34 2 537 42
83. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Y Chen RL Stallings, Cancer Res 2007 67 3 976 83 10.1158/0008-5472.CAN-06-3667 17283129
84. MIR-451 and Imatinib mesylate inhibit tumour growth of Glioblastoma stem cells. H Gal G Pandi AA Kanner Z Ram G Lithwick-Yanai N Amariglio G Rechavi D Givol, Biochem Biophys Res Comm 2008 376 1 86 90 10.1016/j.bbrc.2008.08.107 18765229
85. Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumours. EJ Lee M Baek Y Gusev DJ Brackett GJ Nuovo TD Schmittgen, RNA 2008 14 1 35 42 10.1261/rna.804508 18025253
86. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumour stem cells. J Silber DA Lim C Petritsch AI Persson AK Maunakea M Yu SR Vandenberg DG Ginzinger CD James JF Costello G Bergers WA Weiss A Alvarez-Buylla JG Hodgson, BMC Med 2008 6 14 10.1186/1741-7015-6-14 18577219
87. MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. LT Bemis R Chen CM Amato EH Classen SE Robinson DG Coffey PF Erickson YG Shellman WA Robinson, Cancer Res 2008 68 5 1362 8 10.1158/0008-5472.CAN-07-2912 18316599
88. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumours are associated with distinctive pathologic features and clinical behavior. C Roldo E Missiaglia JP Hagan M Falconi P Capelli S Bersani GA Calin S Volinia CG Liu A Scarpa CM Croce, J of Clin Oncol 2006 24 29 4677 84 10.1200/JCO.2005.05.5194
89. Differential expression of microRNA species in human gastric cancer versus non-tumourous tissues. J Guo Y Miao B Xiao R Huan Z Jiang D Meng Y Wang, J Gastroenterol Hepatol 2009 24 4 652 7 10.1111/j.1440-1746.2008.05666.x 19175831
90. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. LX Yan XF Huang Q Shao MY Huang L Deng QL Wu YX Zeng JY Shao, RNA 2008 14 11 2348 60 10.1261/rna.1034808 18812439
91. MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. S Pizzimenti M Ferracin S Sabbioni C Toaldo P Pettazzoni MU Dianzani M Negrini G Barrera, Free Radic Biol Med 2008 46 2 282 8 10.1016/j.freeradbiomed.2008.10.035 19022373
92. MicroRNA-195 suppresses tumourigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. T Xu Y Zhu Y Xiong YY Ge JP Yun SM Zhuang, Hepatology 2009 50 1 113 21 10.1002/hep.22919 19441017
93. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. T Ichimi H Enokida Y Okuno R Kunimoto T Chiyomaru K Kawamoto K Kawahara K Toki K Kawakami K Nishiyama G Tsujimoto M Nakagawa N Seki, Intl J Cancer 2009 125 2 345 52 10.1002/ijc.24390
94. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. X Hu DM Macdonald PC Huettner Z Feng IM El Naqa JK Schwarz DG Mutch PW Grigsby SN Powell X Wang, Gynaecol Oncol 2009 114 3 457 64 10.1016/j.ygyno.2009. 05.022
95. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. R Baffa M Fassan S Volinia B O'Hara CG Liu JP Palazzo M Gardiman M Rugge LG Gomella CM Croce A Rosenberg, J Path 2009 10 1002
96. EP300 - a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. ST Mees WA Mardin C Wendel N Baeumer E Willscher N Senninger C Schleicher M Colombo-Benkmann J Haier, Intl J Cancer 2009 9999 999A NA
97. Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. Y Du Y Xu L Ding H Yao H Yu T Zhou J Si, J Gastroenterol 2009 44 6 556 61 10.1007/s00535-009-0037-7 19363643
98. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. WC Cho AS Chow JS Au, Eur J of Cancer 2009 45 12 2197 206 10.1016/j.ejca.2009. 04.039
99. MicroRNA expression profiling of thyroid tumours: biological significance and diagnostic utility. MN Nikiforova GC Tseng D Steward D Diorio YE Nikiforov, J Clin Endocrinol Metab 2008 3 5 1600 8 10.1210/jc.2007-2696
100. MicroRNA-373(miR-373) post-transcriptionally regulates large tumour suppressor, homolog 2(LATS2) and stimulates proliferation in human esophageal cancer. KH Lee YG Goan M Hsiao CH Lee SH Jian JT Lin YL Chen PJ Lu, Exp Cell Res 2009 315 15 2529 38 10.1016/j.yexcr.2009.06.001 19501585